Jersey City, NJ, United States of America

Yan Zhang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nimbus Clio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Zhang. Retrieved from https://idiyas.com/inventor/yan-zhang-pe5nr62j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yan Zhang - Innovator in Cbl-b Modulation

Introduction

Yan Zhang is a notable inventor based in Jersey City, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the area of Cbl-b modulation. His work focuses on developing innovative solutions for treating Cbl-b-mediated disorders.

Latest Patents

Yan Zhang holds a patent for "CBL-B modulators and uses thereof." This invention provides compounds and compositions that inhibit Cbl-b, offering potential treatments for various disorders associated with this protein. His patent represents a significant advancement in therapeutic strategies.

Career Highlights

Yan Zhang is currently associated with Nimbus Clio, Inc., where he continues to push the boundaries of innovation in his field. His expertise and dedication have positioned him as a key player in the development of new therapeutic approaches.

Collaborations

Yan collaborates with talented individuals such as Silvana Marcel Leit De Moradei and Angela V West. These partnerships enhance the research and development efforts at Nimbus Clio, Inc., fostering a collaborative environment for innovation.

Conclusion

Yan Zhang's contributions to the field of Cbl-b modulation exemplify the impact of innovative thinking in biomedical research. His work not only advances scientific knowledge but also holds promise for improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…